Novartis AG | TalkMarkets

People who follow this stock (100)

View All

Latest Posts

About This Stock More About This Stock

Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities

Article By: ChinaBio® Today

Saturday, March 23, 2024 2:00 PM EDT

Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Meanwhile, Novo Nordisk announced plans to invest $556 million to expand its Tianjin city production facility.

In this article: MRK, NVO, BGNE, WXXWY, IVBXF, WUXIF Also: NVS, CTLT

Read

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential

Article By: Vision And Value

Thursday, February 22, 2024 6:15 AM EDT

MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.

In this article: MAIA Also: LLY, MRK, NVS, ALPMY, BAYRY, GERN, REGN, TEVA, KURA, IOVA, ZNTL

Read

22 Blue-Chip European Dividend Growth Stocks

Video By: Chuck Carnevale

Friday, February 16, 2024 2:36 PM EDT

A discussion of insights on European dividend growth stocks.

In this video: NVO, NVS, UL, LVMUY, NSRGY

Watch

Diversifying Your Portfolio With Plant-Based Options

Article By: ValueWalk

Thursday, November 16, 2023 6:31 PM EDT

Investors see profit potential in the plant-based market due to rising consumer demand, ESG focus, and the growth of vegan products in various industries, including pharmaceuticals. However, market risks exist.

In this article: GSK, NVS, UL, NSRGY, BYND, OTLY

Read

Week In Review: CMBG Out-Licenses Two CAR-T Candidates To Janssen For $245 Million Upfront

Article By: ChinaBio® Today

Saturday, July 1, 2023 2:58 PM EDT

Cellular Biomedicine Group out-licensed global rights to its two lead CAR-T candidates to Janssen Biotech for $245 million upfront, plus milestones. Also, Shanghai Laekna Therapeutics completed an IPO on the Hong Kong Exchange, raising $100 million.

In this article: MRK, NVS, SGIOY, BPMC, IVBXF, REGMF, BRIBF

Read

All Posts